If the biological conversion of cholest-7-en-3fi-ol (I) into cholesterol (IV) occurred through the intermediacy of cholest-7-ene-3f,,5a-diol (II) then the factor(s) adversely affecting the conversion of the 5a-hydroxy sterol (II) into cholesterol must at least equally adversely affect the formation of cholesterol from cholest-7-en-3f,-ol. By using partial denaturation techniques and dual-labelled precursors it was shown that the enzyme system responsible for the conversion of the 5a-hydroxy sterol (II) into cholesterol denatured faster than that for the corresponding conversion from cholest-7-en-3f,-ol
The Role of a 5a-Hydroxylated Intermediate in the Formation of the 5,6-Double Bond in Cholesterol Biosynthesis
By KEN ALEXANDER and MUHAMMAD AKHTAR Department ofPhysiology andBiochemistry, University ofSouthampton, Southampton S09 5NH, U.K. (Received 5 August 1974) If the biological conversion of cholest-7-en-3fi-ol (I) into cholesterol (IV) occurred through the intermediacy of cholest-7-ene-3f,,5a-diol (II) then the factor(s) adversely affecting the conversion of the 5a-hydroxy sterol (II) into cholesterol must at least equally adversely affect the formation of cholesterol from cholest-7-en-3f,-ol. By using partial denaturation techniques and dual-labelled precursors it was shown that the enzyme system responsible for the conversion of the 5a-hydroxy sterol (II) into cholesterol denatured faster than that for the corresponding conversion from cholest-7-en-3f,-ol (I).
The penultimate stage in the hepatic biosynthesis of cholesterol involves the introduction of the 5,6-double bond in cholest-7-en-3,B-ol (structure I, Scheme 1) to give the 5,7-diene system of 7-dehydrocholesterol (HI), which is then converted into cholesterol (IV) by a NADPH-linked reduction process (Frantz et al., 1959; Dempsey, 1965; Akhtar & Marsh, 1967; Wilton et al., 1968 ; for reviews see Frantz & Schroepfer, 1967; Rees & Goodwin, 1971) . Several years ago we investigated the stereochemical and enzymic aspects of the introduction of the double bond and showed that this process occurs through the overall cis removal of the 50c-and 60c-hydrogen atoms (Akhtar & Marsh, 1967; Paliokas & Schroepfer, 1968; . The stereochemical conclusion was confirmed in subsequent studies by using alternative approaches (Akhtar et al., 1969; Goad et al., 1969) . Two basic mechanisms were considered for the origin of the double bond, a hydroxylation-dehydration mechanism and a dehydrogenation mechanism (Scheme 2) . The hydroxylation-dehydration mechanism requires that one of the three possible hydroxy steroids may an intermediate in the conversion of (I) into (IV). Work of Slaytor & Bloch (1965) had shown that cholest-7-ene-3fli,6fl-diol and cholest-7-ene-3fl,6cx-diol were not involved in the biosynthesis. We synthesized the third potential hydroxylated compound, cholest-7-ene-3,B,5a-diol (II), and noted that this compound was converted into cholesterol, but only under aerobic conditions. The cumulative evidence available at that time did not warrant the consideration of the Sahydroxy sterol (II) as a physiological intermediate in the process under consideration. Topham & Gaylor (1972) described the isolation of an enzyme from yeast which under anaerobic conditions catalysed the conversion of a Sc-hydroxyergost-7-ene derivative (VI) into ergosterol (VIII) by a pathway in which the 3a-hydrogen of compound (VI) was removed. They postulated the pathway shown in Scheme 3 for the dehydration process and argued that the 5cr-hydroxy compound (VI) could be an intermediary in the desaturation process (V-+ VIII). We had previously shown that the main stereochemical and enzymic features of the introduction of the 5,6-double bond in ergosterol biosynthesis by the whole cells of Saccharomyces cerevisiae were remarkably similar to those for the parallel reaction involved in the hepatic biosynthesis of cholesterol and advocated the participation of an 02-dependent dehydrogenation mechanism for both the reactions (Akhtar & Parvez, 1968) .
The new situation arising from the work of Topham & Gaylor (1972) has necessitated further investigation to evaluate the intermediary role of the 5a-hydroxy sterols such as compounds (II) and (VI) in the desaturation processes (I) -+ (III) and (V) --(VIII). In the present paper the relative merits of the two mechanistic alternatives of Scheme 2 have been examined by studying the conversion of cholest-7-en-3f1-ol into cholesterol in rat liver systems.
Materials and Methods

Materials
[26-14C]Cholesterol was obtained from The Radiochemical Centre, Amersham, Bucks., U.K., and converted into [26-14C] cholest-7-en-3fi-ol by the method previously used for the preparation of [4-'4C]cholest-7-en-3fi-ol . These papers also describe the preparation of [3a-3H]cholest-7-ene-3f,5a-diol.
[3x-3H]Cholest-7-en-3fl-ol was prepared from the corresponding unlabelled material by using the oxidation-reduction sequence used for the synthesis 
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of [3a-3Hjcholest-7-ene-3fl,5fi-diol .
Methods
Synthesis of [6,7-3H21cholestane-3fl,5a,8a-triol [6,7-3H2] cholest-7-ene-3fl,5a-diol 3-acetate (20mg; specificradioactivity 3.86 x 107d.p.m./ mmol). The loss ofradioactivity from C-7 on dehydration was 15 %. Therefore the amount of radioactivity at C-6 and C-7 in the diol is 59:41, assuming equal distribution of label in the parent triol. The hydrolysis of the 3-acetoxy group to give [6,7-3H2]cholest-7-ene3fl,5a-diol was performed as described previously for the preparation of the unlabelled material (see the Addendum to .
Since the amount ofradioactivity incorporated into cholesterol from [6,7-3H2] cholest-7-ene-3fl,5a-diol was only halfofthat from [3 a-3H]cholest-7-ene-3f,B5a-diol, we have assumed that the 3H at C-6 of the former compound is removed during the biosynthesis.
Preparation of crude rat liver homogenate. Male Wistar albino rats (100-SOg) were killed by cervical dislocation and the excised livers were homogenized in cold (1-40C) 0.1 M-potassium phosphate buffer, pH7.3, containing 30mM-nicotinamide and 4mM-MgCI2 (1.25ml/g of liver). This buffer was used throughout. The homogenization consisted of 60 strokes in a loose-fitting piston-barrel-type homogenizer. Cell debris and mitochondria were sedimented by centrifugation at l0000gav. for 15min at 1-4°C, after which the supernatant was filtered through glass wool to give the crude rat liver homogenate used in the incubations.
Preparation of subcellular fractions. Table 2 ) only the top half of the 105OOOg supernatant was pipetted off and used for an incubation]. The remaining microsomal pellet was rinsed with cold buffer and resuspended in the same volume of buffer from which it had sedimented. This preparation was used in the 'unwashed microsomal' incubations. The unwashed microsomal preparation was recentrifuged for 1 h at 105000g. The supernatant was then decanted and the microsomal pellet was rinsed with cold buffer and resuspended in the same volume of buffer from which it had sedimented. This preparation was used in the 'washed microsomal' incubations.
All operations in the above preparations were performed at 1-40C.
Incubation procedures. Sterols were dissolved in acetone (1 ml) containing Tween 80 (25mg). The acetone was then removed with a stream of N2 and the residue emulsified in water (0.5ml) before the addition of the rat liver preparation. The crude rat liver homogenates were supplemented with glucose 6-phosphate (1.0mM) and GSH (1.0mM). For the microsomal preparations any NADPH generator added contained 4pmol of glucose 6-phosphate and 0.6unit of glucose 6-phosphate dehydrogenase per 4umol of NADP+. Incubations were performed in 50ml Erlenmeyer flasks at 37'C with gentle shaking. Aerobic conditions were obtained by incubating in unstoppered flasks and anaerobic conditions were obtained by passing purified N2 through the incubation flasks. The N2 was purified from any 02 contamination by bubbling through a solution prepared from sodium anthraquinone ,6-sulphonate (2g)+sodium dithionite (15 g)+KOH (20g) in water (100ml), and was then dried over CaCl2.
Isolation and purification of cholesterol as the 5,6-dibromide derivative. Incubations were terminated by the addition of methanolic 10% (w/v) KOH (5 ml). Non-radioactive carrier cholesterol (100mg) was then added and the mixture was saponified by heating for 5 min on a steam bath. The cholesterol was extracted with ether (3 x 25 ml) and the combined ether extracts were washed with water (3 x 25ml) and saturated NaCl solution (25 ml). After drying over anhydrous Na2SO4 the solvent was removed under reduced pressure. The solid residue was dissolved in ether (l.5ml) 
Results
Status of the 3a-hydrogen atom in the metabolism ofcholest-7-en-3fi-ol and cholest-7-ene-3fi,5a-diol Expts. la, lb and 3 in Table 1 show that when lOO,ug of cholest-7-en-3,B-ol (I) was used under aerobic conditions, over 70% was converted into cholesterol; no significant conversion occurred when the incubation was performed under N2. In comparison with similar amounts of the 5a-hydroxy sterol (II), the conversion into cholesterol was only about 15 %; once again the latter conversion only occurred in the presence of O2 (Expts. 2a and 2b, Table 1 ).
To shed light on the status of the 3 a-hydrogen atom in the conversion (I) --(IV) [3cr-3H,26-14C]cholest-7-en-3,B-ol (3H/14C ratio = 1.14) was aerobically converted with rat liver homogenate into cholesterol which had the same 3H/'4C ratio as the precursor cholest-7-en-3fi-ol (Expt. 3, Table 1 ). The complete retention of the 3 a-3H in the conversion excluded the participation of a pathway of the type shown in Scheme 3 for the biosynthesis.
Next the status of the 3ac-hydrogen atom in the conversion of the 5a-hydroxy sterol (II) into cholesterol was studied. Ideally for this purpose one needed to perform experiments using doubly labelled precursor of the type described above; however, the unavailability of 5cr-hydroxy sterol (II) labelled with 14C necessitated the adoption ofan indirect approach.
[3a-3H]Cholest-7-ene-3f6,5a-diol and [6,7-3H2]cholest-7-ene-3fl,5oc-diol were separately incubated under aerobic and anaerobic conditions. The failure to detect any anaerobic conversion of the 3a-3H-labelled 5a-hydroxy sterol was not due to loss oflabel, since the (6,7-3H2]sterol also remained unmetabolized under the same conditions. Both the [3a-3H]-and the [6,7-3H2]-cholest-7-ene-3fl,5a-diols were converted into cholesterol in good yield under aerobic conditions. Thus, in contrast with the mechanism implicated in ergosterol biosynthesis (Scheme 3), the 5a-hydroxy sterol (II) was only metabolized under aerobic conditions and with the retention of the 3a-hydrogen atorfl.
Subcellular fractions of rat liver participating in the metabolism of cholest-7-en-3fl-ol and cholest-7-ene3f1,5a-diol A systematic study of the subcellular fractions of rat liver was undertaken in an attempt to localize the enzyme systems involved in the metabolism of cholest-7-en-3fi-ol and the 5cr-hydroxy sterol (II). Samples of [26-14C] cholest-7-en-3fi-ol plus [3a-3H]-cholest-7-ene-3f6-diol were incubated with either rat liver homogenate, the top half of the 105OOg supernatant or washed microsomal fraction supplemented with a NADPH generator ( Table 2) . Cholest-7-en-3fl-ol was metabolized by the microsomal preparation but not by the top half of the 105000g supematant. Since the 5a-hydroxy sterol behaved similarly these results neither support nor exclude an intermediary role for this sterol in the metabolism of cholest-7-en-3fi-ol. Evidence in support of independent pathways for the metabolism of cholest-7-en-3fl-ol and cholest-7-ene3f,5a-diol A comparative study of the time-courses for the metabolism of cholest-7-en-3fi-ol and the 5a- N2 0.5 * Corrected amount of cholesterol formed assuming that the 3H at C-6 is lost during the metabolism of the 6,7-3H2-labelled 50c-hydroxy sterol substrate and that the ratio of 3H at C-6/C-7 is 59:41 (see the Materials and Methods section).
1975 cholest-7-en-3fl-ol; *, cholesterol biosynthesized from cholest-7-ene-3fl,5a-diol. [26-'4C] cholest-7-en-3,f-ol (I) (5.89 x 104d.p.m./,umol) were aerobically incubated for 180min with rat liver homogenate (IO.Oml) that had been preincubated for various time-intervals. The [3a-3H,26-14C]cholesterol formed was isolated as the dibromide. In both the experiments the 3H/'4C ratio of cholesterol obtained when the homogenate was not subjected to any preincubation has been normalized to the value of 1.0. In an allied experiment a comparative examination of the effect of partial denaturation of the rat liver homogenate on the conversion of the 5a-hydroxy sterol and cholest-7-en-3fl-ol into cholesterol was made. The homogenate was aerobically preincubated at 37°C and after various time-intervals 1O.Oml of the homogenate was transferred to successive flasks, each of which contained both the sterols to minimize differences in experimental conditions for the two substrates. As indicated in Table 3 the conversion of the 5a-hydroxy sterol into cholesterol was more sensitive to the denaturation of the enzyme system than was the conversion of cholest-7-en-ol into cholesterol. This can be clearly seen by the significant decrease in the 3H/14C ratio of the biosynthesized cholesterol with increasing periods of preincubation. It is notable that in Expt. la (Table 3) , as in previous experiments in Table 1 , equal quantities of cholest-7-en-3#-ol and the 5a-hydroxy sterol being used as substrates, a smaller amount of cholesterol was biosynthesized from the 5ar-hydroxy sterol than from cholest-7-en-3,f-ol. When a similar experiment was performed, in which the relative amounts of cholest-7-en-3fl-ol and the 5a-hydroxy sterol were adjusted to give approximately equal amounts of cholesterol, essentially the same results were obtained (Expt. lb, Table 3 ).
Discussion
We have confirmed our previous finding that the 5a-hydroxy sterol (II) is converted into cholesterol only under aerobic conditions and that this sterol (II) is a less efficient precursor of cholesterol than cholest-7-en-3fi-ol (1) . Experiments carried out with doubly labelled cholest-7-en3f,-ol have shown that the introduction of the 5,6-double bond in the biological conversion (I) -* (IV) does not involve the loss of the 3a-hydrogen atom, as might have been expected if the reaction involved first the hydroxylation of cholest-7-en-3/8-ol to the 5a-hydroxy sterol (II) and then its dehydration by a pathway postulated for the corresponding reaction in the ergosterol series and outlined in Scheme 3 (Topham & Gaylor, 1972) .
The most compelling evidence against the involvement of the Sa-hydroxy sterol (II) as a direct intermediate in the conversions (I) -+ (IV) came from partial-denaturation experiments. It was shown that theenzyme system responsible for the conversion of the Sa-hydroxy sterol (II) into cholesterol denatured faster than that for the corresponding conversion from cholest-7-en-3fi-ol (I) . If the biological conversion of cholest-7-en-3,B-ol (I) into cholesterol occurred through the intermediary of the Sa-hydroxy sterol (II) then the factors adversely affecting the conversion of the 5a-hydroxy sterol (II) into cholesterol (IV) must also similarly affect the formation of cholesterol from cholest-7-en-3fl-ol (I). This was not the case (Table 3) . We therefore deduce that the 5-hydroxy sterol (II) is not involved in an intermediary role during the conversion of cholest-7-en-311-ol into cholesterol.
We may now examine the basis of the observation which has emphasized the role of the 5a-hydroxyergostene derivative (VI) in the formation of the 5,6-double bond in ergosterol biosynthesis. Topham & Gaylor (1972) have described the purification of an enzyme system which converted $a-hydroxyergostene derivative (VI) into ergosterol under anaerobic conditions by a mechanism involving the loss of the 3a-hydrogen atom. These workers argued that this loss of 3a-hydrogen atom may explain the inability in our original work (Akhtar & Parvez, 1968) to detect any conversion of [3a-3H]ergosta-7,22-diene3fl,5a-diol (VI) into ergosterol with anaerobically growing yeast cells. Topham & Gaylor (1972) , however, overlooked the fact that in the same work a satisfactory conversion of (3a-3H]ergosta-7,22-diene-3f6,5a-diol into ergosterol was obtained by using aerobically growing yeast cells (Akhtar & Parvez, 1968) .
More important, however, from a mechanistic viewpoint were the results obtained when [3a-3H]-ergosta-7,22-dien-3f,-ol (V) was incubated with whole yeast cells. Up to 88 % of the incubated radioactivity was recovered in the harvested cells and was associated with a sterol fraction; of this about 36% was actually incorporated into ergosterol (Akhtar & Parvez, 1968) . If we make the extreme assumption that the 12% unaccounted-for radioactivity may represent the loss of 3a-3H in the formation of ergosterol then a conservative conclusion may be drawn that for every 100 molecules of [3a-3H]-ergosta-7,22-dien-3/J-ol (V) committed to ergosterol biosynthesis 75 completed their journey retaining the 3ca-hydrogen atom. If the enzyme system described by Topham & Gaylor (1972) for the metabolism of the Sa-hydroxyergostene derivative (VI) was obligatorily involved in the biosynthesis in vivo then in the In the light of these considerations we reaffirm our original conclusion that the introduction of the 5,6-double bond in cholesterol biosynthesis occurs through an 02-dependent dehydrogenation process . In view of close similarities between the rat liver and the yeast systems a similar mechanism may be involved for the corresponding reaction, (V) -+ (VIII), in ergosterol biosynthesis.
A hypothetical mechanism previously considered for the introduction of the 5,6-double bond in cholesterol biosynthesis is illustrated in Scheme 4. According to this, oxygen interacts with a highly reduced group -X: (e.g. a metal in its reduced form) of the enzyme to form the enzyme-oxygen species, which is then involved in the cis removal of the two hydrogen atoms as shown in Scheme 4.
It was suggested that this mechanism, predicting a cis elimination, may represent a general biological principle for the formation of ethylenic linkages involving C-H bonds not activated by electronwithdrawing groups .
This mechanism was consistent with observations on the biosynthesis of ethylenic linkages in oleic acid, linoleic acid, a-linolenic acid and arachidonic acid (Light et al., 1962; Schroepfer & Bloch, 1965; Stoffel & Schiefer, 1966; Morris et al., 1968) . In particular Stoffel & Schiefer (1966) showed that in the biosynthesis of arachidonic acid 02 could not be replaced by artificial electron acceptors. In the steroid field the cis elimination of hydrogen atoms in metabolism of cholesterol into cholest-7-en-3f1-ol was readily explicable by a process similar to Scheme 4 (Clayton & Edwards, 1963) . Since the proposal ofthis mechanism, extensive studies, particularly at the University of Liverpool, have shown that the formation of trans-double bonds in the side chains ofporiferasterol and ergosterol, as well as a variety of cis-double bonds in ring B of steroids by fungi, higher plants, algae, protozoa and mammals, all occur through the cis elimination of hydrogen atoms (Akhtar & Parvez, 1968; Smith et al., 1968a,b; Bimpson et al., 1969a,b; Goad et al., 1969; Wilton & Akhtar, 1970; Zander & Caspi, 1970; Mulheirn et al., 1971) . Scallen & Schuster (1968) and also considered an alternative mechanism, involving the transfer of one of the hydrogen atoms of the steroid (I) to nicotinamide nucleotides, for the desaturation reaction (I) -+ (III). Using 6a-3H-labelled compound (I) showed that the 6a-hydrogen atom of the substrate was not transferred to NADH; corresponding experiments with the 5ca-3H substrate were, however, not performed. The formation of the 7,8-double bond in ecdysone biosynthesis also occurs with the overall cis removal of 7f1-and 8,B-hydrogen atoms. Preliminary evidence suggests that in this case the 71)-hydrogen atoms may be transferred to nicotinamide nucleotides (Cook et al., 1973) .
